Diebold Nixdorf, Incorporated (DBD) Guidance & Earnings Results
On 2026-07-29 Diebold Nixdorf, Incorporated reaffirmed guidance: "Full-year 2026: revenue $3.86B-$3.94B, adjusted EBITDA $510M-$535M, free cash flow $255M-$270M, adjusted EPS…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DBDDiebold Nixdorf, IncorporatedFollow DBD — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- 22.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 29 Jul 26 | Reaffirmed | Full-year 2026: revenue $3.86B-$3.94B, adjusted EBITDA $510M-$535M, free cash flow $255M-$270M, adjusted EPS $5.25-$5.75. · full year |
| 30 Apr 26 | Reaffirmed | FY2026 guidance reaffirmed: Revenue $3.86B-$3.94B, Adj. EBITDA $510M-$535M, FCF $255M-$270M, Adj. EPS $5.25-$5.75 · full year |
| 12 Feb 26 | Raised | FY2026: revenue $3.86-3.94B; adjusted EBITDA $510-535M; FCF $255-270M; adjusted EPS $5.25-5.75 · full year |
| 5 Nov 25 | Reaffirmed | Total revenue flat to up low single-digits; Adjusted EBITDA $470M-$490M; Free Cash Flow $190M-$210M · full year |
| 6 Aug 25 | Reaffirmed | FY2025 revenue flat to up low single-digits; adjusted EBITDA $470M-$490M; free cash flow $190M-$210M; trending toward higher end of range · full year |
Diebold Nixdorf, Incorporated — questions
- What guidance did Diebold Nixdorf, Incorporated give?
- On 2026-07-29: "Full-year 2026: revenue $3.86B-$3.94B, adjusted EBITDA $510M-$535M, free cash flow $255M-$270M, adjusted EPS $5.25-$5.75."
- When does Diebold Nixdorf, Incorporated report earnings?
- Diebold Nixdorf, Incorporated's next earnings report is expected on 2026-10-28.
Every figure on this page comes from Diebold Nixdorf, Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.